JP2020511940A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020511940A5 JP2020511940A5 JP2019530426A JP2019530426A JP2020511940A5 JP 2020511940 A5 JP2020511940 A5 JP 2020511940A5 JP 2019530426 A JP2019530426 A JP 2019530426A JP 2019530426 A JP2019530426 A JP 2019530426A JP 2020511940 A5 JP2020511940 A5 JP 2020511940A5
- Authority
- JP
- Japan
- Prior art keywords
- adenovirus
- acid sequence
- amino acid
- seq
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662432033P | 2016-12-09 | 2016-12-09 | |
| US62/432,033 | 2016-12-09 | ||
| US201762465378P | 2017-03-01 | 2017-03-01 | |
| US62/465,378 | 2017-03-01 | ||
| PCT/IB2017/057759 WO2018104919A1 (en) | 2016-12-09 | 2017-12-08 | Chimpanzee adenovirus constructs with lyssavirus antigens |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020511940A JP2020511940A (ja) | 2020-04-23 |
| JP2020511940A5 true JP2020511940A5 (enExample) | 2021-01-21 |
| JP7118062B2 JP7118062B2 (ja) | 2022-08-15 |
Family
ID=60955374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019530426A Active JP7118062B2 (ja) | 2016-12-09 | 2017-12-08 | リサウイルス抗原を有するチンパンジーアデノウイルス構築物 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20220112245A2 (enExample) |
| EP (1) | EP3551644B1 (enExample) |
| JP (1) | JP7118062B2 (enExample) |
| CN (1) | CN110036020A (enExample) |
| BR (1) | BR112019010275A2 (enExample) |
| CA (1) | CA3045976A1 (enExample) |
| ES (1) | ES2959811T3 (enExample) |
| MX (1) | MX2019006722A (enExample) |
| WO (1) | WO2018104919A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2903582C (en) | 2013-03-14 | 2021-06-08 | Salk Institute For Biological Studies | Oncolytic adenovirus compositions |
| JP7015551B2 (ja) | 2016-02-23 | 2022-02-15 | ソーク インスティテュート フォー バイオロジカル スタディーズ | ウイルス動態への影響を最小限にするための治療用アデノウイルスにおける外因性遺伝子発現 |
| WO2017147265A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | High throughput assay for measuring adenovirus replication kinetics |
| CA3045892A1 (en) | 2016-12-12 | 2018-06-21 | Salk Institute For Biological Studies | Tumor-targeting synthetic adenoviruses and uses thereof |
| CA3062591A1 (en) | 2017-05-08 | 2018-11-15 | Gritstone Oncology, Inc. | Alphavirus neoantigen vectors |
| CN111108203A (zh) * | 2017-07-17 | 2020-05-05 | 葛兰素史密丝克莱恩生物有限公司 | 狂犬病病毒抗原构建体 |
| BR112020019942A2 (pt) | 2018-04-09 | 2021-01-26 | Salk Institute For Biological Studies | composições de adenovírus oncolítico com propriedades de replicação aprimoradas |
| KR102077772B1 (ko) * | 2018-11-29 | 2020-02-17 | 주식회사 바이오앱 | 광견병 예방용 백신 조성물 및 이의 제조 방법 |
| WO2020121273A1 (en) | 2018-12-14 | 2020-06-18 | Glaxosmithkline Biologicals Sa | Heterologous prime boost vaccine compositions and methods |
| MX2021014525A (es) * | 2019-05-30 | 2022-03-17 | Gritstone Bio Inc | Adenovirus modificados. |
| BR112021025025A2 (pt) * | 2019-06-11 | 2022-02-22 | Glaxosmithkline Biologicals Sa | Formulações de vacinas de mucosa |
| US20230234992A1 (en) | 2020-06-05 | 2023-07-27 | Glaxosmithkline Biologicals Sa | Modified betacoronavirus spike proteins |
| WO2022077330A1 (zh) * | 2020-10-15 | 2022-04-21 | 中国科学院深圳先进技术研究院 | 一种新型g基因及其在高效逆向跨单突触中的应用 |
| CN112210565B (zh) * | 2020-10-15 | 2022-07-29 | 中国科学院深圳先进技术研究院 | 一种g基因及其在高效逆向跨单突触中的应用 |
| CN114591922A (zh) * | 2022-03-30 | 2022-06-07 | 长睿生物技术(成都)有限公司 | 一种表达狂犬病毒g蛋白的重组黑猩猩源腺病毒及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5698202A (en) * | 1995-06-05 | 1997-12-16 | The Wistar Institute Of Anatomy & Biology | Replication-defective adenovirus human type 5 recombinant as a rabies vaccine carrier |
| ES2322043T3 (es) * | 2001-06-22 | 2009-06-16 | The Wistar Institute Of Anatomy And Biology | Procedimientos de indusccion de una respuesta citotoxica inmune y composiciones de adenovirus de simio recombinante utiles en los mismos. |
| ES2871907T3 (es) * | 2004-01-23 | 2021-11-02 | Msd Italia Srl | Portadores de vacuna de adenovirus de chimpancé |
| EP2220217A2 (en) | 2007-11-28 | 2010-08-25 | The Trustees of the University of Pennsylvania | Simian subfamily c adenoviruses sadv-40, -31, and-34 and uses thereof |
| WO2010085984A1 (en) | 2009-02-02 | 2010-08-05 | Okairos Ag | Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof |
| MX2011007980A (es) | 2009-02-02 | 2011-08-17 | Okairos Ag | Secuencias de acido nucleico y aminoacido de adenovirus de simio, vectores que contienen los mismos y usos de las mismas. |
| WO2012089231A1 (en) | 2010-12-30 | 2012-07-05 | Okairòs Ag | Paramyxovirus vaccines |
| JP6091435B2 (ja) | 2011-02-22 | 2017-03-08 | カリフォルニア インスティチュート オブ テクノロジー | アデノ随伴ウイルス（ａａｖ）ベクターを用いたタンパク質の送達 |
| IN2014DN03005A (enExample) | 2011-10-05 | 2015-05-08 | Genvec Inc | |
| JP6757120B2 (ja) | 2011-10-05 | 2020-09-16 | ジェンヴェック エルエルシー | アーフェンアデノウイルス（ゴリラ）又はアデノウイルスベクター、及び使用方法 |
| CN103987726B (zh) | 2011-10-05 | 2017-10-03 | 金维克有限公司 | 猴(大猩猩)腺病毒或腺病毒载体及其使用方法 |
| WO2015119291A1 (ja) * | 2014-02-10 | 2015-08-13 | 有限会社生物資源研究所 | ウイルス様粒子 |
| CN106659777A (zh) * | 2014-06-13 | 2017-05-10 | 葛兰素史密丝克莱恩生物有限公司 | 免疫原性组合产品 |
| EA038402B9 (ru) * | 2015-06-12 | 2021-09-22 | Глаксосмитклайн Байолоджикалс Са | Аденовирусные полинуклеотиды и полипептиды |
-
2017
- 2017-12-08 ES ES17828782T patent/ES2959811T3/es active Active
- 2017-12-08 MX MX2019006722A patent/MX2019006722A/es unknown
- 2017-12-08 BR BR112019010275A patent/BR112019010275A2/pt not_active Application Discontinuation
- 2017-12-08 CN CN201780074503.5A patent/CN110036020A/zh active Pending
- 2017-12-08 JP JP2019530426A patent/JP7118062B2/ja active Active
- 2017-12-08 WO PCT/IB2017/057759 patent/WO2018104919A1/en not_active Ceased
- 2017-12-08 EP EP17828782.7A patent/EP3551644B1/en active Active
- 2017-12-08 CA CA3045976A patent/CA3045976A1/en not_active Abandoned
- 2017-12-08 US US16/467,569 patent/US20220112245A2/en not_active Abandoned
-
2022
- 2022-12-05 US US18/075,064 patent/US20230158134A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020511940A5 (enExample) | ||
| CN111108192B (zh) | 非人类人猿腺病毒核酸序列和氨基酸序列、含有其的载体及其用途 | |
| JP2020511114A5 (enExample) | ||
| JP2018523980A5 (enExample) | ||
| CN105112428B (zh) | 猿腺病毒核酸和氨基酸序列，包含其的载体及其用途 | |
| JP2018524977A5 (enExample) | ||
| JP2014516536A5 (enExample) | ||
| JP2015057052A5 (enExample) | ||
| US9133248B2 (en) | Methods of propagating monkey adenoviral vectors | |
| US20210269827A1 (en) | Modified serotype 28 adenoviral vectors | |
| US12180512B2 (en) | Simian adenoviral vectors with two expression cassettes | |
| WO2019076877A1 (en) | ADENOVIRAL VECTORS FOR REPLICATION | |
| US20220364115A1 (en) | Enhanced promoter | |
| TWI901715B (zh) | 大猩猩腺病毒核酸及胺基酸序列，包含彼之載體，及其用途 | |
| HK40031047A (en) | Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof | |
| HK40031047B (en) | Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof | |
| NZ759892B2 (en) | Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof | |
| WO2004108939A2 (en) | Bav packaging regions and e1 transcriptional control regions |